project id: TCGA-COAD; case submitter id: TCGA-A6-A5ZU; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; age at index: 59; days to birth: -21554; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1954; age at diagnosis: 21554; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 293.0; icd 10 code: C18.4; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Transverse colon; synchronous malignancy: No; tissue or organ of origin: Transverse colon; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 50; days to sample procurement: 0; initial weight: 480.0; portion submitter id: TCGA-A6-A5ZU-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 27.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;